You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Precursor%20Cell%20Lymphoblastic%20Leukemia-Lymphoma

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 12, 2022

Binge Drinking, Folate Deficiency Trial in Tulsa (Methyl Folate, Placebo)

Active, not recruiting
  • Binge Drinking
  • Folate Deficiency
  • Methyl Folate
  • Placebo
  • Tulsa, Oklahoma
    Oklahoma State University Center for Health Sciences
Apr 19, 2022

Pancreatic Ductal Adenocarcinoma Trial in Milan (Chlorambucil, Oral, 2 Mg)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Chlorambucil, Oral, 2 Mg
  • Milan, Italy
    IRCCS San Raffaele
Dec 30, 2020

Antibiotics-unresponsive MALT Lymphoma, Relapsed MALT Type Extranodal Marginal Zone B-Cell Lymphoma, Refractory Extranodal

Not yet recruiting
  • Antibiotics-unresponsive MALT Lymphoma
  • +2 more
  • Lenalidomide [Leavdo®]
  • Taipei, Taiwan
    National Taiwan University Hospital
Oct 25, 2020

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (JCAR017, Durvalumab,

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • JCAR017
  • +7 more
  • Duarte, California
  • +17 more
Jan 13, 2023

Colorectal Tumors Trial in New York (Botensilimab, Balstilimab)

Not yet recruiting
  • Colorectal Neoplasms
  • New York, New York
    Weill Cornell Medicine/NewYork-Presbyterian Hospital
Jan 24, 2023

Carcinoma,Non-Small-Cell Lung, Lung Carcinomas, Non-Small-Cell, Non-small-cell Lung Carcinoma Trial in Worldwide (Pemetrexed,

Active, not recruiting
  • Carcinoma，Non-Small-Cell Lung
  • +3 more
  • Albury, New South Wales, Australia
  • +192 more
Sep 19, 2022

Degenerative Spine Diseases Trial in Bologna (Vertebral bone marrow (vBMA) clot, Bone allograft chips)

Recruiting
  • Degenerative Spine Diseases
  • Vertebral bone marrow (vBMA) clot
  • Bone allograft chips
  • Bologna, BO, Italy
    Istituto Ortopedico Rizzoli
Jul 14, 2023

Obesity, Obesity, Abdominal, Insulin Resistance Trial in Kyiv, Lviv (Postbiotic, Placebo)

Recruiting
  • Obesity
  • +5 more
  • Postbiotic
  • Placebo
  • Kyiv, Ukraine
  • +3 more
Mar 14, 2023

Sclerotherapy and Bone Marrow Injection In Aneurysmal Bone Cyst

Not yet recruiting
  • Orthopedic Disorder
  • Sclerotherapy With Adjuvant Bone Marrow Injection In Management of Aneurysmal Bone Cyst
  • (no location specified)
Jan 23, 2023

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

Active, not recruiting
Has Results
  • BRCA1 Gene Mutation
  • +5 more
  • Durvalumab
  • +3 more
  • Buffalo, New York
  • +1 more
Jan 20, 2023

Systemic Inflammatory Response Syndrome Trial in Madrid (Allogeneic thyTreg 5.000.000, Allogeneic thyTreg 10.000.000)

Recruiting
  • Systemic Inflammatory Response Syndrome
  • Allogeneic thyTreg 5.000.000
  • Allogeneic thyTreg 10.000.000
  • Madrid, Spain
    Hospital General Universitario Gregorio Marañon
Sep 22, 2023

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission Trial in Bronx,

Terminated
Has Results
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • Adult Acute Myeloid Leukemia in Remission
  • Bronx, New York
  • +2 more
May 4, 2020

Celiac Disease Trial in Boston (Gluten Powder)

Recruiting
  • Celiac Disease
  • Gluten Powder
  • Boston, Massachusetts
    Celiac Research Centre Mass General Hospital
Jul 1, 2022

Giant Cell Arteritis Trial in France (color Doppler ultrasound and TAB in case of CDU negative)

Completed
  • Giant Cell Arteritis
  • color Doppler ultrasound and TAB in case of CDU negative
  • Angoulême, France
  • +5 more
Apr 19, 2022

Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma Trial in United States (Cisplatin,

Recruiting
  • Advanced Bile Duct Carcinoma
  • +33 more
  • Sacramento, California
  • +6 more
Aug 11, 2022

Characterization of the Melanoma-Specific Immune Response

Recruiting
  • Melanoma
    • Sacramento, California
      University of California, Davis Department of Dermatology
    Nov 3, 2021

    Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

    Completed
    Has Results
    • Chronic Myeloid Leukemia
    • Omacetaxine mepesuccinate
    • Los Angeles, California
    • +31 more
    Nov 11, 2021

    Acute Myelocytic Leukemia, Myelodysplastic Syndrome Trial in Germany (Azacitidine)

    Completed
    • Acute Myelocytic Leukemia
    • Myelodysplastic Syndrome
    • Berlin, Germany
    • +10 more
    Nov 12, 2021

    HER2-negative Early Breast Cancer Trial in Beijing (neoadjuvant chemo upon in vitro PTC drug sensitivity screening for triple

    Recruiting
    • HER2-negative Early Breast Cancer
    • neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for triple negative breast cancer
    • neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for luminal like breast cancer
    • Beijing, China
      Peking University People's Hospital
    Mar 27, 2022

    Either EML4-ALK Gene Rearrangements or T790M EGFR Mutation in

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
      • Hollywood, Florida
      • +1 more
      Sep 29, 2021

      Study (EPIPHANY)

      Recruiting
      • Chemotherapy-induced Peripheral Neuropathy
        • Tucson, Arizona
        • +11 more
        Feb 28, 2022

        CIBMTR Research Database

        Recruiting
        • Autologous Stem Cell Transplantation
        • +6 more
          • Minneapolis, Minnesota
          • +1 more
          Jan 20, 2023

          Clear Cell Papillary Renal Tumor, Collecting Duct Carcinoma, Hereditary Leiomyomatosis and Renal Cell Carcinoma Trial in Los

          Recruiting
          • Clear Cell Papillary Renal Neoplasm
          • +10 more
          • Los Angeles, California
            UCLA / Jonsson Comprehensive Cancer Center
          Oct 25, 2021

          Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia-2, High Grade Malignant Tumor Trial in

          Completed
          Has Results
          • Blasts 10 Percent or More of Bone Marrow Nucleated Cells
          • +8 more
          • Seattle, Washington
            Fred Hutch/University of Washington Cancer Consortium
          Oct 11, 2021